Showing results (71-80 of 107) with videos related to

Sort By:
Pageof 11
Cancers|March 11, 2023
Inter- and Intra-Observer Agreement of PD-L1 SP142 Scoring in Breast Carcinoma-A Large Multi-Institutional International StudyMohamed Zaakouk, Mieke Van Bockstal, Christine Galant, et al.
BMJ Open|September 29, 2025
FAST MRI: DYAMOND trial protocol (can an abbreviated MRI scan detect breast cancers missed by mammography for screening clients with average mammographic density attending their first screening mammogram?)-a diagnostic yield study within the NHS population-risk breast screening programmeLyn Isobel Jones, Rebecca Geach, Abi Loose, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2008
Nuclear and cytoplasmic expression of ERbeta1, ERbeta2, and ERbeta5 identifies distinct prognostic outcome for breast cancer patientsAbeer M Shaaban, Andrew R Green, Suchita Karthik, et al.
Breast Cancer Research and Treatment|September 13, 2005
A multi-centre investigation towards reaching a consensus on the immunohistochemical detection of ERbeta in archival formalin-fixed paraffin embedded human breast tissuePauline J Carder, Claire E Murphy, Peter Dervan, et al.
Histopathology|February 14, 2013
Outcome of pure mucocele-like lesions diagnosed on breast core biopsyEmad A Rakha, Abeer M Shaaban, Syeda Asma Haider, et al.
International Journal of Molecular Sciences|July 13, 2024
Pathological Changes Following Neoadjuvant Endocrine Therapy (NAET): A Multicentre Study of 391 Breast CancersIslam M Miligy, Nahla Badr, Andrea Stevens, et al.
Oncotarget|June 2, 2016
The Hippo transducers TAZ/YAP and their target CTGF in male breast cancerAnna Di Benedetto, Marcella Mottolese, Francesca Sperati, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 7, 2023
European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSOIsabel T Rubio, Lynda Wyld, Lorenza Marotti, et al.
Journal of Cellular Physiology|December 18, 2016
Association between AXL, Hippo Transducers, and Survival Outcomes in Male Breast CancerAnna Di Benedetto, Marcella Mottolese, Francesca Sperati, et al.
Scientific Reports|October 8, 2016
HMG-CoAR expression in male breast cancer: relationship with hormone receptors, Hippo transducers and survival outcomesAnna Di Benedetto, Marcella Mottolese, Francesca Sperati, et al.
Pageof 11